Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

South Korea says up to medical personnel to extract extra doses of COVID vaccine from vial

Published 03/02/2021, 03:00 AM
Updated 03/02/2021, 03:05 AM
© Reuters. COVID-19 vaccination in South Korea

© Reuters. COVID-19 vaccination in South Korea

By Sangmi Cha

SEOUL (Reuters) - A decision by South Korean health authorities to allow more doses to be extracted from coronavirus vaccine vials sparked controversy on Tuesday as the country ramped up its vaccinations of healthcare workers and the elderly.

The Korea Disease Control and Prevention Agency (KDCA) had allowed healthcare workers to use the remaining doses if they can squeeze more out of each vial with low dead space syringes, which minimize the amount of vaccine left in the syringe after use.

While offering discretion over the use of remaining doses, KDCA made clear the authorities will not make the extraction of the extra doses a new standard or mandatory as it can burden the healthcare workers on site.

Experts were divided about the decision for permitting up to seven doses to be extracted from Pfizer (NYSE:PFE) vaccine vials which are made to contain only six using the low dead space syringes, and up to 12 doses from AstraZeneca (NASDAQ:AZN)'s vaccine, which would otherwise inoculate 10 people with normal syringes.

Eom Joong-sik, professor of infectious diseases at Gachon University Gil Medical Center, warned of the risk of contamination during inaccurate extraction of the extra seventh dose.

A worker trying to combine leftovers from two vials to make a full dose could lead to such problems, Eom said in a Facebook (NASDAQ:FB) post.

The government hasn't made it mandatory to squeeze extra dose out of a vial and there is a designated person in charge of extraction in large medical centres, which makes it easier for them to draw an extra dose safely, said Ki Mo-ran, professor of cancer control and population health at National Cancer Center.

KDCA said 23,086 people were given first doses of AstraZeneca and Pfizer shots by Monday midnight.

© Reuters. COVID-19 vaccination in South Korea

South Korea has reported 344 new cases on Monday, adding to the total tally of 90,372, with 1,606 deaths.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.